540.05
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
United Therapeutics CFO James Edgemond sells $5.48m in shares - Investing.com
United Therapeutics CEO Martine Rothblatt sells $5.2m in company stock - Investing.com
United Therapeutics CEO Rothblatt sells $863,947 in stock By Investing.com - Investing.com India
United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.47% Potential Upside - DirectorsTalk Interviews
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock - Insider Monkey
United Therapeutics CEO Rothblatt exercises, sells $5.37m in stock - Investing.com UK
United Therapeutics CEO Rothblatt exercises, sells $5.37m in stock By Investing.com - Investing.com South Africa
UTHR Stock Price, Quote & Chart | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill
United Therapeutics Corporation (UTHR) Latest Stock News & Headlines - Yahoo Finance
UTHRUnited Therapeutics Corp Stock Price and Quote - Finviz
United Therapeutics Corp at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
United Therapeutics CEO Martine Rothblatt sells $5.38m UTHR shares - Investing.com India
United Therapeutics CEO Martine Rothblatt sells $5.38m UTHR shares By Investing.com - Investing.com India
United Therapeutics CEO Rothblatt sells $5.4m in common stock By Investing.com - Investing.com India
United Therapeutics Explores Pig Heart Transplants And Space Labs As Valuation Lags - Yahoo Finance
United Therapeutics stock rating reiterated at Buy by TD Cowen - Investing.com South Africa
United Therapeutics CEO Rothblatt sells $5.4m in common stock - Investing.com
Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
United Therapeutics (UTHR) Remains a Key Holding for Renaissance Technologies - GuruFocus
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.4m in stock - Investing.com Nigeria
United Therapeutics (UTHR) Reports TETON Study Results on Nebuli - GuruFocus
Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.4m in stock By Investing.com - Investing.com South Africa
United Therapeutics’ Tyvaso meets primary endpoint in IPF trial - Investing.com
Inhaled Tyvaso preserves lung function, cuts IPF risks in trial - Stock Titan
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial - marketscreener.com
United Therapeutics (UTHR) Reports Positive Ralinepag Results in Pulmonary Hypertension Study - GuruFocus
Baidu, Brady And 3 Stocks To Watch Heading Into Monday - Benzinga
Experimental PAH pill ralinepag cuts worsening risk 55% in Phase 3 - Stock Titan
Leuthold Group LLC Buys 3,126 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics stock (US9113631090): FDA clears first UHeart xenotransplantation trial - AD HOC NEWS
United Therapeutics Corporation $UTHR Stock Position Decreased by Thrivent Financial for Lutherans - MarketBeat
5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings Call - Yahoo Finance
United Therapeutics Corporation Announces Fda Clearance to Proceed with Uheart Xenotransplantation Clinical Trial - marketscreener.com
United Therapeutics stock (US9113631090): fresh data push at ATS 2026 keeps pipeline in focus - AD HOC NEWS
자본화:
|
볼륨(24시간):